The art of prescribing: Mitigating cognitive side effects associated with topiramate

Perspectives in Psychiatric Care

Volumn 41, Issue 2, 2005, Pages 92-93

  Antai Otong, Deborah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE; TOPIRAMATE;

BRAIN LEVEL; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; DRUG ADMINISTRATION; DRUG EFFECT; DRUG MONITORING; HUMAN; MEMORY DISORDER; METHODOLOGY; MOOD DISORDER; NEUROBIOLOGY; PSYCHOLOGICAL RATING SCALE; REVIEW;

ANTICONVULSANTS; BRAIN CHEMISTRY; COGNITION DISORDERS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FRUCTOSE; HUMANS; MEMORY DISORDERS; MOOD DISORDERS; NEUROBIOLOGY; PSYCHIATRIC STATUS RATING SCALES;

EID: 22144467691     PISSN: 00315990     EISSN: 17446163     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2005.00018.x     Document Type: Short Survey

References (17)

1. Andrade, C. (2001). Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder. Bipolar Disorder, 3, 211 212.
2. Baeta, E., Santana, I., Castro, G., Goncalves, S., Goncalves, T., Carmo, I. Carito, A.I. (2002). Cognitive effects of therapy with topiramate in patients with refractory partial seizures. Review of Neurology, 34, 737 741.
3. Biton, V., Edwards, K.R., Montouris, G.D., Sackellares, J.C., Harden, C.L., Kamin, M., Topiramate, & TPS-TRStudyGroup (2001). Topiramate titration and tolerability. The Annals of Pharmacotherapy, 35, 173 179.
4. Chengappa, K.N.R., Gershon, S. Levine, J. (2001). The evolving role of topiramate among mood disorders in the management of bipolar disorder. Bipolar Disorder, 3, 215 232.
5. Evins, A.E. (2003). Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders. Journal of Clinical Psychiatry, 64 (suppl. 8), 9 14.
6. Grunze, H.C., Normann, C., Langosch, J., Schaefer, M., Amann, B., Sterr, A., Schloesser, S., Kleindienst, N. Walden, J. (2001). Journal of Clinical Psychiatry, 62, 464 468.
7. Gupta, S., Masand, P.S., Frank, G.L., Lockwood, K.L. Keller, P.L. (2000). Topiramate in bipolar and schizoaffective disorders: Weight loss and efficacy. Primary Care Companion. Journal of Clinical Psychiatry, 2, 96 100.
8. LaRoche, S.M. Helmers, S.L. (2004). The new antiepileptic drugs: Scientific review. Journal of the American Medical Association, 291, 605 614.
9. Lee, S., Sziklas, V., Andermann, F., Farnham, S., Risse, G., Gustafson, M., Gates, J., Penovich, P., Al-Asmi, A., Dubeau, F. Jones-Gotman, M. (2003). The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia, 44, 339 347.
10. Lykouras, L. Hatzimanolis, J. (2004). Adjunctive topiramate in the maintenance treatment of bipolar disorders: An open-label study. Current Medical Research and Opinion, 20, 843 847.
11. Maidment, I.D. (2002). The use of topiramate in mood stabilization. Annals of Pharmacotherapy, 36, 1277 1281.
12. McIntyre, R.S., Mancini, D.A., McCann, S., Srinivasan, J., Sagman, D. Kennedy, S.H. (2002). Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: A preliminary single-blind study. Bipolar Disorder, 4, 207 213.
13. Ojemann, L.M., Ojemann, G.A., Dodrill, C.B., Crawford, C.A., Holmes, M.D. Dudley, D.L. (2001). Language disturbances as side effects of topiramate and zonisamide therapy. Epilepsy Behavior, 2, 579 584.
14. Petty, F. (1995). GABA and mood disorders: A brief review and hypothesis. Journal of Affective Disorders, 34, 275 281.
15. Shorvon, S. (1996). Safety of topiramate: Adverse events and relationships to dosing. Epilepsia, 37 (suppl. 2), S18 S22.
16. Spina, E. Perugi, G. (2004). Antiepileptic drugs: Indications other than epilepsy. Epileptic Disorders, 6, 57 75.
17. Yatham, L.N. (2004). Newer anticonvulsants in the treatment of bipolar disorder. Journal of Clinical Psychiatry, 65 (suppl. 10), 28 35.